-+ 0.00%
-+ 0.00%
-+ 0.00%

On September 17, Huadong Pharmaceutical announced that its wholly-owned subsidiary Xinkeli Aesthetic Medical Technology Co., Ltd. and Beijing Meibai Pharmaceutical Biotechnology Development Co., Ltd. and Hunan Meibai Biomedical Co., Ltd. have formally signed a strategic cooperation agreement to reach an exclusive strategic cooperation on extracellular matrix collagen MB007 products in the Chinese market.

Zhitongcaijing·09/17/2026 08:09:05
Listen to the news
On September 17, Huadong Pharmaceutical announced that its wholly-owned subsidiary Xinkeli Aesthetic Medical Technology Co., Ltd. and Beijing Meibai Pharmaceutical Biotechnology Development Co., Ltd. and Hunan Meibai Biomedical Co., Ltd. have formally signed a strategic cooperation agreement to reach an exclusive strategic cooperation on extracellular matrix collagen MB007 products in the Chinese market.